Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of Hold from Analysts

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. […]

Related Keywords

,Acadian Asset Management ,Enanta Pharmaceuticals Inc ,Nasdaq ,Armistice Capital ,Enanta Pharmaceuticals Stock Performance ,News Ratings For Enanta Pharmaceuticals Daily ,Jpmorgan Chase Co ,Analyst Recommendations For Enanta Pharmaceuticals ,Enanta Pharmaceuticals ,Institutional Investors Weigh In On Enanta Pharmaceuticals ,Vanguard Group Inc ,Krensavage Asset Management ,Get Free Report ,Asset Management ,Get Free ,Enanta Pharmaceuticals Daily ,